| Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer (NCT01324323) | Celgene | 2011-04-01 |
| AMG 319 Lymphoid Malignancy FIH (NCT01300026) | Amgen | 2011-04-01 |
| Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment (NCT01334580) | Yale University | 2011-04-01 |
| A Study on The Effect of Multiple Dose Carbamazepine on Single Dose Pharmacokinetics of RO4917838 in Healthy Volunteers (NCT01365403) | Hoffmann-La Roche | 2011-04-01 |
| The Effect of Chymosin on the Intestinal Absorption of Calcium (NCT01370941) | University of Aarhus | 2011-04-01 |
| Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy (NCT01324856) | University of Belgrade | 2011-04-01 |
| A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma (NCT01220271) | Eli Lilly and Company | 2011-04-01 |
| Drug-drug Interaction of Empagliflozin (BI 10773) and Microgynon (NCT01328184) | Boehringer Ingelheim | 2011-04-01 |
| The Safety and Immunogenicity of DTP/Hepatitis B 10ug Hib Vaccine (Bio Farma) (NCT01977196) | PT Bio Farma | 2011-04-01 |
| Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer (NCT01347788) | Massachusetts General Hospital | 2011-04-01 |
| Dose Escalation Study Investigating Everolimus and Dovitinib in Metastatic Clear Cell Renal Cancer (NCT01714765) | Queen Mary University of London | 2011-04-01 |
| NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement (NCT01408472) | Jeffrey L Goldberg | 2011-04-01 |
| Autologous Stem Cells for Spinal Cord Injury (SCI) in Children (NCT01328860) | Aryn Knight | 2011-04-01 |
| Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®) (NCT01311505) | Pfizer | 2011-04-01 |
| Study of Sildenafil Citrate on Insulin Resistance in African American (NCT01334554) | Vanderbilt University Medical Center | 2011-04-01 |
| Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia (NCT00962715) | M.D. Anderson Cancer Center | 2011-04-01 |
| Safety and Pharmacokinetic Profiles of Two Formulations of CO-1.01 in Patients With Advanced Solid Tumors (NCT01392976) | Clovis Oncology, Inc. | 2011-04-01 |
| Safety Study of an Oral Vaccine to Prevent Avian Influenza (NCT01335347) | Vaxart | 2011-04-01 |
| A Pharmacodynamic Study of Dapoxetine Concomitantly Administered in Participants Taking Terazosin (NCT01366664) | Janssen Research & Development, LLC | 2011-04-01 |
| A Healthy Volunteer Study to Evaluate for a Single Dose of 4 Different Tablets of DPOC-4088 the Absorption and Elimination From the Body and the Potential Effect on Blood Clotting (NCT01347203) | Diakron Pharmaceuticals | 2011-04-01 |
| A Bioequivalence (BE) Study Comparing The Commericializable And Clinical Formulations Of PF-00299804 (NCT01313793) | Pfizer | 2011-04-01 |
| A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects (NCT01332565) | ViiV Healthcare | 2011-04-01 |
| Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer (NCT01324310) | Celgene | 2011-04-01 |
| Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes (NCT01399346) | Medical University of Graz | 2011-04-01 |
| Sildenafil in Single Ventricle Patients (NCT01169519) | Duke University | 2011-04-01 |
| Interactive Medication Reconciliation By Secure Messaging (NCT01564446) | VA Boston Healthcare System | 2011-04-01 |
| Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men. (NCT01293487) | Pfizer | 2011-04-01 |
| The Effect of Food on the Administration of Canagliflozin in Healthy Adult Volunteers (NCT01343290) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2011-04-01 |
| Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury (NCT01479777) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2011-04-01 |
| Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc) (NCT01328990) | London School of Hygiene and Tropical Medicine | 2011-04-01 |
| Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use (NCT01344629) | Boehringer Ingelheim | 2011-04-01 |
| Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects (NCT01290211) | ViiV Healthcare | 2011-04-01 |
| Building Complex Language (NCT01337232) | Governors State University | 2011-04-01 |
| Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates (NCT01378923) | George Mason University | 2011-04-01 |
| Topical Betaxolol for the Prevention of Retinopathy of Prematurity (NCT01660620) | Smith-Kettlewell Eye Research Institute | 2011-04-01 |
| Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies (NCT01118819) | BioMed Valley Discoveries, Inc | 2011-04-01 |
| The Altura Abdominal Aortic Aneurysm (AAA) Endograft Safety and Feasibility Study (NCT01346943) | Altura Medical Inc. | 2011-04-01 |
| Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients (NCT01336062) | Peking University | 2011-04-01 |
| Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors (NCT01343498) | SCRI Development Innovations, LLC | 2011-04-01 |
| A Study to Compare Two Different Tablet Formulations of AZD8931 in Healthy Males and Females (NCT01330758) | AstraZeneca | 2011-04-01 |
| Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL) (NCT01504776) | Anand Jillella | 2011-04-01 |
| Scopolamine Challenge Study (NCT01213355) | Pfizer | 2011-04-01 |
| Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors (NCT01336842) | University of California, Davis | 2011-04-01 |
| Periodontal Tissue Regeneration Using Autologous Periodontal Ligament Stem Cells (NCT01357785) | Air Force Military Medical University, China | 2011-04-01 |
| Bioactivity of Olive Oils Enriched With Their Own Phenolic Compounds (VOHF1) (NCT01347515) | University Rovira i Virgili | 2011-04-01 |
| Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer (NCT01255800) | University of Colorado, Denver | 2011-04-01 |
| A Study to Evaluate the Pharmacokinetics of the Hydrocodone Extended-Release Tablet (CEP-33237) in Subjects With Normal Hepatic Function and Subjects With Moderate Hepatic Impairment (NCT01319279) | Cephalon | 2011-04-01 |
| Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition (NCT01603173) | IPCA Laboratories Ltd. | 2011-04-01 |
| A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways (NCT01310322) | AstraZeneca | 2011-04-01 |
| Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients (NCT01334047) | Steinar Aamdal | 2011-04-01 |
| Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) (NCT01329549) | Boehringer Ingelheim | 2011-04-01 |
| A Study to Compare the Pharmacokinetic Profiles of DW224aa and DW224a (NCT01341249) | Seoul National University Hospital | 2011-04-01 |
| A Study of LY2409021 Formulations and the Effect of Food (NCT01354496) | Eli Lilly and Company | 2011-04-01 |
| Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation (NCT01027689) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers (NCT01325051) | Angela Kashuba, PharmD | 2011-04-01 |
| Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia (NCT01362036) | Tarix Pharmaceuticals | 2011-04-01 |
| Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC) (NCT01335074) | Philipps University Marburg | 2011-04-01 |
| Safety and Comfort of AL-4943A Ophthalmic Solution (NCT01326858) | Alcon Research | 2011-04-01 |
| Role of Turmeric on Oxidative Modulation in ESRD Patients (NCT01906840) | Shiraz University of Medical Sciences | 2011-04-01 |
| Virtual World Health Behavior Counseling for Patients With Diabetes (NCT01340079) | Boston Medical Center | 2011-04-01 |
| Single Rising Dose Study to Assess Safety, Tolerability and Pharmacokinetics of BI 661051. (NCT01343719) | Boehringer Ingelheim | 2011-04-01 |
| Safety, Preliminary Pharmacokinetics and Bronchodilator Properties of V0162 (NCT01348555) | Pierre Fabre Medicament | 2011-04-01 |
| A Study of RO6807952 in Patients With Diabetes Mellitus Type 2 (NCT01358929) | Hoffmann-La Roche | 2011-04-01 |
| Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia (NCT01373515) | Mendus | 2011-04-01 |
| New Treatment Option for Pancreatic Cancer (NCT01364805) | Jeanne Drisko, MD, CNS, FACN | 2011-04-01 |
| Electrochemotherapy as a Palliative Treatment for Brain Metastases (NCT01322100) | Copenhagen University Hospital at Herlev | 2011-04-01 |
| A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous Conivaptan (NCT01370148) | Cumberland Pharmaceuticals | 2011-04-01 |
| Phase I Study of OPB-51602 in Patients With Hematologic Malignancies (NCT01344876) | Otsuka Pharmaceutical Co., Ltd. | 2011-04-01 |
| Clinical Study of Vaginal Lactobacilli and Estriol (Gynoflor®) for Atrophic Vaginitis in Breast Cancer Patients (NCT01370551) | Medinova AG | 2011-04-01 |
| A Two-Part, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DS-7309 in Healthy Volunteers and Subjects With Type 2 Diabetes Mellitus (NCT01862939) | Daiichi Sankyo | 2011-04-01 |
| Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation (NCT01285505) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2011-04-01 |
| A Open-label Study to Evaluate the Relative Bioavailability of Samatasvir (IDX184) and Food Effect in Healthy Male Participants (MK-2355-006) (NCT01335607) | Merck Sharp & Dohme LLC | 2011-04-01 |
| Autologous Cytomegalovirus (CMV) Specific CD8+ T Cells as Treatment for CMV Reactivation (NCT01326273) | Imperial College London | 2011-04-01 |
| Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence (NCT01340066) | Beech Tree Labs, Inc. | 2011-04-01 |
| Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT01342887) | Fred Hutchinson Cancer Center | 2011-04-01 |
| Assess the Safety, Tolerability and Pharmacokinetics of AZD5213 After Single and Multiple Ascending Oral Doses in Healthy Young and Elderly Japanese Subjects (NCT01335451) | AstraZeneca | 2011-04-01 |
| A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT01312389) | Abramson Cancer Center at Penn Medicine | 2011-04-01 |
| A Study of Resveratrol as Treatment for Friedreich Ataxia (NCT01339884) | Murdoch Childrens Research Institute | 2011-04-01 |
| A Pilot Study to Evaluate the Effect of Pomegranate Juice on Semen Parameters in Healthy Male Volunteers (NCT01595308) | POM Wonderful LLC | 2011-04-01 |
| Hepatocyte Matrix Implant Study Indonesia (NCT01335568) | Baermed | 2011-04-01 |
| Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010) (NCT01337674) | Merck Sharp & Dohme LLC | 2011-04-01 |
| Bioequivalence Study of Azacitidine for Injection in Myelodysplastic Syndrome (MDS) Patients (NCT01152346) | Bioniche Pharma USA LLC | 2011-04-01 |
| Pharmacokinetic Drug Interaction Between Revaprazan and Itopride HCl in Healthy Male Subjects (NCT01332890) | Yuhan Corporation | 2011-04-01 |
| Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer (NCT01205022) | City of Hope Medical Center | 2011-04-01 |
| Drug-drug Interaction Study(CKD-501, Amlodipine) (NCT01341392) | Chong Kun Dang Pharmaceutical | 2011-04-01 |
| Study of AHIST in Seasonal Allergic Rhinitis Patients (NCT01008397) | Magna Pharmaceuticals, Inc. | 2011-04-01 |
| Single Dose FSH-GEX™ in Healthy Volunteers (NCT01354886) | Glycotope GmbH | 2011-04-01 |
| Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy (NCT01643044) | Wayne State University | 2011-04-01 |
| A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies (NCT01325441) | Sumitomo Pharma America, Inc. | 2011-04-01 |
| A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (NCT01297764) | Hackensack Meridian Health | 2011-04-01 |
| A Study to Explore the Routes of Elimination of MDV3100 (NCT01911715) | Astellas Pharma Europe B.V. | 2011-04-01 |
| Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors (NCT01331135) | Emory University | 2011-04-01 |
| GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study (NCT01336244) | Lakefront Biotherapeutics NV | 2011-04-01 |
| Effects of Deep Brain Stimulation in Treatment Resistant Major Depression (NCT01095263) | University Hospital, Bonn | 2011-04-01 |
| Effects Of PF-02545920 On Ketamine-Induced Abnormal Prefrontal Brain Response To Associative Learning In Healthy Subjects (NCT01244880) | Pfizer | 2011-04-01 |
| NT-501 CNTF Implant for Ischemic Optic Neuropathy: Safety, Neuroprotection and Neuroenhancement (NCT01411657) | Jeffrey L Goldberg | 2011-04-01 |
| A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia (NCT01340482) | Kyowa Kirin Co., Ltd. | 2011-04-01 |
| A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1) (NCT01311882) | Merck Sharp & Dohme LLC | 2011-04-01 |
| Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH) (NCT01335165) | Alexion Pharmaceuticals, Inc. | 2011-04-01 |
| Single Ascending Dose Study of RBP-7000 (NCT02768649) | Indivior Inc. | 2011-04-01 |